$8.01
-0.3-3.61%
At Close: -
$7.89
-0.12-1.50%
After Hours: Sep 20, 5:12 PM EDT
15 minutes delayed
Ginkgo Bioworks Holdings reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Ginkgo Bioworks Holdings using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-08 | $-4.40 | $-3.20 | -37.5 % |
Mar 2024 | 2024-05-09 | $-3.20 | $-3.20 | 0.00 % |
Dec 2023 | 2024-02-29 | $-4.40 | $-4.00 | -10.0 % |
Sep 2023 | 2023-11-08 | $-6.40 | $-3.60 | -77.8 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-08 | $56.21M | $43.71M | 28.6 % |
Mar 2024 | 2024-05-09 | $37.94M | $46.04M | -17.6 % |
Dec 2023 | 2024-02-29 | $34.76M | $42.50M | -18.2 % |
Sep 2023 | 2023-11-08 | $55.43M | $48.08M | 15.3 % |
Ginkgo Bioworks Holdings (DNA) is scheduled to report earnings on November 6, 2024. The last reported earnings were for reported on August 8, 2024 for Q2.
The Actual EPS was $-4.40, which missed the estimate of $-3.20.
The Actual Revenue was $56.2M, which beat the estimate of $43.7M.
Browse earnings estimates, EPS, and revenue on all stocks.